Logo image of MKL

MARKEL GROUP INC (MKL) Stock Fundamental Analysis

USA - NYSE:MKL - US5705351048 - Common Stock

1878.89 USD
-17.29 (-0.91%)
Last: 10/24/2025, 8:04:00 PM
1878.89 USD
0 (0%)
After Hours: 10/24/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MKL. MKL was compared to 147 industry peers in the Insurance industry. MKL has a medium profitability rating, but doesn't score so well on its financial health evaluation. MKL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MKL was profitable.
MKL had a positive operating cash flow in the past year.
Of the past 5 years MKL 4 years were profitable.
In the past 5 years MKL always reported a positive cash flow from operatings.
MKL Yearly Net Income VS EBIT VS OCF VS FCFMKL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

MKL's Return On Assets of 3.22% is fine compared to the rest of the industry. MKL outperforms 68.71% of its industry peers.
MKL has a Return On Equity (12.42%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.22%
ROE 12.42%
ROIC N/A
ROA(3y)2.38%
ROA(5y)2.8%
ROE(3y)8.69%
ROE(5y)9.72%
ROIC(3y)N/A
ROIC(5y)N/A
MKL Yearly ROA, ROE, ROICMKL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 13.07%, MKL is in the better half of the industry, outperforming 75.51% of the companies in the same industry.
MKL's Profit Margin has declined in the last couple of years.
MKL has a better Operating Margin (20.40%) than 80.27% of its industry peers.
MKL's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.4%
PM (TTM) 13.07%
GM N/A
OM growth 3Y-3.99%
OM growth 5Y-3%
PM growth 3Y-6.22%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MKL Yearly Profit, Operating, Gross MarginsMKL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

3

2. Health

2.1 Basic Checks

MKL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MKL has less shares outstanding
The number of shares outstanding for MKL has been reduced compared to 5 years ago.
Compared to 1 year ago, MKL has a worse debt to assets ratio.
MKL Yearly Shares OutstandingMKL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MKL Yearly Total Debt VS Total AssetsMKL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

MKL has a debt to FCF ratio of 2.13. This is a good value and a sign of high solvency as MKL would need 2.13 years to pay back of all of its debts.
MKL's Debt to FCF ratio of 2.13 is in line compared to the rest of the industry. MKL outperforms 55.10% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that MKL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.25, MKL is doing good in the industry, outperforming 63.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.13
Altman-Z N/A
ROIC/WACCN/A
WACC7.96%
MKL Yearly LT Debt VS Equity VS FCFMKL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MKL Yearly Current Assets VS Current LiabilitesMKL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.53% over the past year.
MKL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.39% yearly.
The Revenue has been growing slightly by 1.66% in the past year.
MKL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.78% yearly.
EPS 1Y (TTM)9.53%
EPS 3Y4.51%
EPS 5Y13.39%
EPS Q2Q%-48.52%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y8.97%
Revenue growth 5Y11.78%
Sales Q2Q%20.56%

3.2 Future

The Earnings Per Share is expected to grow by 13.31% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.46% on average over the next years.
EPS Next Y32.26%
EPS Next 2Y22.49%
EPS Next 3Y18.88%
EPS Next 5Y13.31%
Revenue Next Year-4.27%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.52%
Revenue Next 5Y3.46%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MKL Yearly Revenue VS EstimatesMKL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
MKL Yearly EPS VS EstimatesMKL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 50 -50 100

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.10 indicates a quite expensive valuation of MKL.
Based on the Price/Earnings ratio, MKL is valued a bit more expensive than 79.59% of the companies in the same industry.
When comparing the Price/Earnings ratio of MKL to the average of the S&P500 Index (26.89), we can say MKL is valued inline with the index average.
MKL is valuated rather expensively with a Price/Forward Earnings ratio of 17.15.
Based on the Price/Forward Earnings ratio, MKL is valued a bit more expensive than 65.31% of the companies in the same industry.
MKL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.1
Fwd PE 17.15
MKL Price Earnings VS Forward Price EarningsMKL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.71% of the companies in the same industry are more expensive than MKL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MKL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.6
EV/EBITDA 6.6
MKL Per share dataMKL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800 1K

4.3 Compensation for Growth

MKL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MKL's earnings are expected to grow with 18.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.93
PEG (5Y)2.25
EPS Next 2Y22.49%
EPS Next 3Y18.88%

0

5. Dividend

5.1 Amount

No dividends for MKL!.
Industry RankSector Rank
Dividend Yield N/A

MARKEL GROUP INC

NYSE:MKL (10/24/2025, 8:04:00 PM)

After market: 1878.89 0 (0%)

1878.89

-17.29 (-0.91%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners82.81%
Inst Owner Change-0.03%
Ins Owners1.41%
Ins Owner Change0.34%
Market Cap23.77B
Revenue(TTM)16.45B
Net Income(TTM)2.15B
Analysts50.77
Price Target2018.58 (7.43%)
Short Float %1.58%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.78
Dividend Growth(5Y)N/A
DP1.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.29%
Min EPS beat(2)-45.1%
Max EPS beat(2)36.52%
EPS beat(4)2
Avg EPS beat(4)-18.28%
Min EPS beat(4)-119.59%
Max EPS beat(4)55.06%
EPS beat(8)5
Avg EPS beat(8)-22.64%
EPS beat(12)8
Avg EPS beat(12)-9.57%
EPS beat(16)12
Avg EPS beat(16)4.5%
Revenue beat(2)1
Avg Revenue beat(2)4.72%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)16.08%
Revenue beat(4)1
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)16.08%
Revenue beat(8)3
Avg Revenue beat(8)4.69%
Revenue beat(12)6
Avg Revenue beat(12)5.81%
Revenue beat(16)7
Avg Revenue beat(16)3.3%
PT rev (1m)0%
PT rev (3m)0.89%
EPS NQ rev (1m)2.68%
EPS NQ rev (3m)1.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.84%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)3.95%
Valuation
Industry RankSector Rank
PE 30.1
Fwd PE 17.15
P/S 1.44
P/FCF 11.6
P/OCF 10.49
P/B 1.37
P/tB 1.85
EV/EBITDA 6.6
EPS(TTM)62.42
EY3.32%
EPS(NY)109.56
Fwd EY5.83%
FCF(TTM)161.91
FCFY8.62%
OCF(TTM)179.08
OCFY9.53%
SpS1300.72
BVpS1369.02
TBVpS1017.74
PEG (NY)0.93
PEG (5Y)2.25
Graham Number1386.62
Profitability
Industry RankSector Rank
ROA 3.22%
ROE 12.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 20.4%
PM (TTM) 13.07%
GM N/A
FCFM 12.45%
ROA(3y)2.38%
ROA(5y)2.8%
ROE(3y)8.69%
ROE(5y)9.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.99%
OM growth 5Y-3%
PM growth 3Y-6.22%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.13
Debt/EBITDA 1.18
Cap/Depr 63.44%
Cap/Sales 1.32%
Interest Coverage 250
Cash Conversion 61.24%
Profit Quality 95.24%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)81.13%
Cap/Depr(5y)63.91%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.53%
EPS 3Y4.51%
EPS 5Y13.39%
EPS Q2Q%-48.52%
EPS Next Y32.26%
EPS Next 2Y22.49%
EPS Next 3Y18.88%
EPS Next 5Y13.31%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y8.97%
Revenue growth 5Y11.78%
Sales Q2Q%20.56%
Revenue Next Year-4.27%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.52%
Revenue Next 5Y3.46%
EBIT growth 1Y13.76%
EBIT growth 3Y4.62%
EBIT growth 5Y8.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.41%
FCF growth 3Y3.19%
FCF growth 5Y15.24%
OCF growth 1Y-19.01%
OCF growth 3Y4.48%
OCF growth 5Y15.28%

MARKEL GROUP INC / MKL FAQ

What is the ChartMill fundamental rating of MARKEL GROUP INC (MKL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to MKL.


What is the valuation status of MARKEL GROUP INC (MKL) stock?

ChartMill assigns a valuation rating of 3 / 10 to MARKEL GROUP INC (MKL). This can be considered as Overvalued.


Can you provide the profitability details for MARKEL GROUP INC?

MARKEL GROUP INC (MKL) has a profitability rating of 4 / 10.


Can you provide the financial health for MKL stock?

The financial health rating of MARKEL GROUP INC (MKL) is 3 / 10.


What is the expected EPS growth for MARKEL GROUP INC (MKL) stock?

The Earnings per Share (EPS) of MARKEL GROUP INC (MKL) is expected to grow by 32.26% in the next year.